• About WordPress
    • WordPress.org
    • Documentation
    • Learn WordPress
    • Support
    • Feedback
  • Log In
  • Register
Skip to content
Endocannabinoid Science Education Endocannabinoid Science Education

ECS is Physiology

  • What?
  • Why?
  • How?
  • Where?
  • Contact
  • Advisory Board
  • Forums
  • Blog
  • Bio
  • ECS Explained
Endocannabinoid Science Education
Endocannabinoid Science Education

ECS is Physiology

Endocannabinoid System (ECS)

Liraglutide, 2‑AG and the Microbiome: A New Gut–Brain Pathway for Antidepressant Effects

Posted on June 17, 2026 By Stefan Broselid

From metabolic drug to mood modulator A new paper in Cell Host & Microbe has just delivered one of the most compelling mechanistic stories yet for how the endocannabinoid system (ECS) links metabolic drugs, the gut microbiome, and mood regulation. The study shows that the antidepressant effects of the GLP‑1…

Read more
Endocannabinoid System (ECS) Illustration of a lean fat-1 mouse and a plumper wild-type mouse to explain the fat-1 mouse endocannabinoid system and different membrane fatty acid profiles

The Mouse That Can’t Get Fat — and What It Reveals About Your Endocannabinoid System

Posted on June 14, 2026June 14, 2026 By Stefan Broselid

There is a mouse that refuses to follow the script. Feed it a high-fat Western diet for sixteen months and it stays leaner, its gut stays tighter, its blood stays cleaner, and its cells age more slowly. Not because of a drug. Because of one change: the balance of fats…

Read more
Endocannabinoid System (ECS) Split-screen illustration of two doctors, one of whom is ECS-literate. The blog post title is overlaid: 'ECS Literacy in Medicine: Why It Makes Better Doctors'

ECS Literacy in Medicine: Why It Makes Better Doctors

Posted on May 26, 2026May 26, 2026 By Stefan Broselid

What happens to clinical reasoning when a physician understands the endocannabinoid system? Seven conditions, two kinds of doctors, and the reasoning gap that a better curriculum could close.

Read more
Endocannabinoid System (ECS) Jigsaw puzzle of fatty liver disease with a new insulin→CB1 piece connecting insulin spikes to hepatic CB1 and steatosis, leaving some gaps for unknown mechanisms.

How Poor Diet and Insulin Spikes Disrupt the Endocannabinoid System and Drive Fatty Liver

Posted on May 21, 2026May 21, 2026 By Stefan Broselid

Scientists have identified a new mechanism linking everyday diet to endocannabinoid system (ECS) dysfunction: normal post‑meal insulin spikes can increase CB1 receptors in the liver by about 50% by slowing their lysosomal recycling. Together with an omega‑6‑heavy fat intake, this amplifies diet‑driven steatosis and helps explain how common foods drive fatty liver disease.

Read more
Critical analysis Three-panel diagram showing how dietary linoleic acid (LA) input, modulated by FADS desaturase activity, leads to divergent outcomes: high plasma LA with low downstream omega-6 (favorable) versus low plasma LA with high downstream omega-6 (inflammatory/ECS-driven)

Low plasma linoleic acid is a marker of high FADS activity – not a license to drink seed oil

Posted on May 6, 2026May 6, 2026 By Stefan Broselid

A new UK Biobank paper on omega‑6 and adiposity just landed, and if you only read the abstract, you’d think the story was simple: higher linoleic acid (LA) in plasma is “protective” against obesity and therefore we should be recommending more LA‑rich oils to everyone. Look one level deeper, and…

Read more
Endocannabinoid System (ECS) Blog header illustration for how an omega-3 RCT reveals a hidden layer of presumed ECS restoration. ECS.education logotype visible to the right.

Why an Omega-3 Trial for Anxiety Accidentally Proved Something Far More Interesting About Your Endocannabinoid System

Posted on March 16, 2026March 16, 2026 By Stefan Broselid

A new randomised, double-blind, placebo-controlled trial published in the Journal of Affective Disorders set out to test whether omega-3 supplementation improves stress, anxiety, depression, sleep quality, and memory in people with severe psychological distress (Azhar et al., 2025). The trial was conducted on a Saudi population, was reasonably well-designed, and produced striking…

Read more
Endocannabinoid System (ECS)

Your ECS Under Load: Regular Cannabis, Exercise, and a Blunted Runner’s High

Posted on March 2, 2026March 2, 2026 By Stefan Broselid

Your ECS under load, not at rest Most cannabis conversations live in the acute space: “How does it feel when I’m high?” or in vague long‑term boxes like “motivation” or “psychosis risk.” Almost nobody asks the more mechanistic question that actually matters for resilience:​ What does your endocannabinoid system do…

Read more
Critical analysis Divided illustration contrasting mainstream omega-6 fatty acid research on left with neglected endocannabinoid system CB1 CB2 receptor pathways anandamide 2-AG hidden behind broken wall on right alongside cannabis leaf and ignored research files

The Missing System: How a Major 2026 Review on Cardiometabolic Health Ignores the Endocannabinoid System

Posted on February 2, 2026February 2, 2026 By Stefan Broselid

Last August, I wrote about a troubling pattern in inflammation research: brilliant scientists studying arachidonic acid metabolism while remaining “blissfully unaware that half the arachidonic acid story exists in a parallel research universe.” I documented how eicosanoid researchers and endocannabinoid scientists study the same substrate, same concentration ranges, same tissues—yet publish in…

Read more
Endocannabinoid System (ECS) Minimalist illustration showing a central dial without markings, positioned over a faint brain outline. The dial balances two opposing arrows labeled ‘Symptom Control’ and ‘Cognitive Function,’ with a hand hovering uncertainly above it, symbolizing the trade-off between therapeutic efficacy and cognitive safety in medical cannabis use without knowledge of CB1 receptor availability.

The Medical Cannabis Paradox: How Tolerance Threatens Long-Term Therapeutic Success

Posted on January 24, 2026January 24, 2026 By Stefan Broselid

A follow-up to “CB1 Availability as a Non-Invasive Biomarker: Bridging Endocannabinoid System Dysfunction and Therapeutic Monitoring“ The Emerging Evidence: Tolerance is Real and Quantifiable A recent study published in Frontiers in Pharmacology (2025) provided the first systematic measurement of how tolerance accumulates during medical cannabis treatment (Stith et al., 2025). Using real-world…

Read more
Endocannabinoid System (ECS) The new inverted food pyramid and text that says "The New US Dietary Guidelines" and "Eat to Support Your ECS". ECS.education logotype is visible to the right.

The New US Dietary Guidelines: Eat to Support Your ECS

Posted on January 16, 2026January 16, 2026 By Stefan Broselid

This article explains how the endocannabinoid system is shaped by diet, especially omega‑6 and omega‑3 fats. The 2025–2030 US Dietary Guidelines process is quietly doing something profound. On the surface, it might look like another technical update about fat intake, unsaturated oils, and seafood recommendations. But underneath that familiar language sits…

Read more
  • 1
  • 2
  • …
  • 8
  • Next
©2026 Endocannabinoid Science Education | WordPress Theme by SuperbThemes